Uma Sinha, Chief Scientific Officer at Eidos Therapeutics, Inc. (EIDX), sold 17,700 shares at $125.35 ($2.2M) on 2021-01-13, disclosed to the SEC on 2021-01-15.
Open-market sale of $2.2M EIDX by Chief Scientific Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $121.11 | 696 | $84K | 3.8% |
| 2 | $121.11 | 696 | $84K | 3.8% |
| 3 | $122.27 | 572 | $70K | 3.2% |
| 4 | $122.27 | 572 | $70K | 3.2% |
| 5 | $123.48 | 1,498 | $185K | 8.4% |
| 6 | $123.48 | 1,498 |
| $185K |
| 8.4% |
| 7 | $124.72 | 4,934 | $615K | 28.0% |
| 8 | $124.72 | 4,934 | $615K | 28.0% |
| 9 | $125.35 | 2,000 | $251K | 11.4% |
| 10 | $126.39 | 300 | $38K | 1.7% |
| Total | $124.17 avg | 17,700 | $2.2M | 100% |
| Filing → |
| EIDX | SELL | 2020-10-02 | $515K | — | Filing → |
| EIDX | SELL | 2019-12-20 | $1.5M | — | Filing → |
| EIDX | SELL | 2019-09-27 | $96K | — | Filing → |